Lux Médica · Mar 3, 2026

Association between frailty syndrome and albumin in patients with chronic kidney disease on hemodialysis

By Alcalá FGL, Álvarez JDJ

INTRODUCTION: Frailty is a condition that can help us stratify both risk and prognosis in patients with chronic kidney disease; low albumin in these same patients is associated with worsening of the former, especially in those undergoing renal replacement therapies. OBJECTIVE: To evaluate the association between frailty syndrome and albumin in patients with chronic kidney disease on hemodialysis. MATERIALS AND METHODS: An observational, cross-sectional, analytical study was conducted, which was carried out in the hemodialysis unit at Hospital General de Zona Nº 3 in Jesús María, Aguascalientes, from October to November 2023, with 20 patients in the sample meeting the selection criteria; descriptive and inferential statistical analyses were performed. RESULTS: Of the 20 patients, 65% were women. The prevalence of frailty was observed to be 35%, while 20% were classified as prefrail, and, as a final result, it was found that there is indeed an association between frailty syndrome and albumin. CONCLUSIONS: The FRAIL scale is a useful and easy-to-administer instrument for identifying frailty in patients with chronic kidney disease on hemodialysis, and albumin also provides a biochemical tool that can even be used to decide on screening for it and to intervene early from that point. RECEIVED: 09/08/2024 APPROVED: 04/02/2026

doi.org/10.33064/61lm20256537Open accessBiomarkers

AgingResearch.News